Recent Patents on Inflammation & Allergy Drug Discovery
Title:ACKNOWLEDGEMENTS TO CONTRIBUTORS (2015):
Volume: 9 Issue: 2
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS TO CONTRIBUTORS (2015):, Recent Patents on Inflammation & Allergy Drug Discovery 2015; 9 (2) . https://dx.doi.org/10.2174/1872213X0902160211151500
DOI https://dx.doi.org/10.2174/1872213X0902160211151500 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
16
Related Articles
-
Magnolia officinalis Reduces Inflammation and Damage Induced by Recurrent Status Epilepticus in Immature Rats
Current Pharmaceutical Design Effective Chemicals against Novel Coronavirus (COVID-19) in China
Current Topics in Medicinal Chemistry Mechanisms of Activation and Key Roles of SGK3 Under Physiological Conditions and in Prostate and Breast Cancer
Current Signal Transduction Therapy Structural Determinants and Molecular Mechanisms for the Resistance of HIV-1 RT to Nucleoside Analogues
Current Drug Metabolism Sumoylation Pathway as Potential Therapeutic Targets in Cancer
Current Molecular Medicine Artificial Carriers: A Strategy for Constructing Antigenic/Immunogenic Conjugates
Current Topics in Medicinal Chemistry Evolution of Reactive mPEG Polymers for the Conjugation of Peptides and Proteins
Current Organic Chemistry Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets Myeloma Cells and Their Interactions With the Bone Marrow Endothelial Cells
Current Immunology Reviews (Discontinued) Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial
Current Vascular Pharmacology The Immunological Functions of Muramyl Dipeptide Compound Adjuvant on Humoral, Cellular-mediated and Mucosal Immune Responses to PEDV Inactivated Vaccine in Mice
Protein & Peptide Letters Subject Index to Volume 5
Current Drug Targets Choice of Treatment with Antidepressants: Influencing Factors
Current Pharmaceutical Design The Neurobiological Bases for Development of Pharmacological Treatments of Aggressive Disorders
Current Neuropharmacology New Life to an Old Treatment: Pegylated Interferon Beta 1a in the Management of Multiple Sclerosis
Current Medicinal Chemistry COX-2 Inhibition in Esophagitis, Barretts Esophagus and Esophageal Cancer
Current Pharmaceutical Design Chemokines and their Receptors as Targets for the Treatment of COPD
Current Respiratory Medicine Reviews Elevated Homocysteine Levels in Parkinsons Disease: Is there Anything Besides L-Dopa Treatment?
Current Medicinal Chemistry PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis
Current Drug Targets - Inflammation & Allergy